Process for the alkoxycarbonylation of ethers

Abstract

The invention relates to a process comprising the following process steps: a) introducing an ether having 3 to 30 carbon atoms; b) adding a phosphine ligand and a compound which comprises Pd, or adding a complex comprising Pd and a phosphine ligand; c) adding an alcohol; d) supplying CO; e) heating the reaction mixture, the ether being reacted for form an ester; where the phosphine ligand is a compound of formula (I) ##STR00001##
where m and n are each independently 0 or 1; R.sup.1, R.sup.2, R.sup.3, R.sup.4 are each independently selected from (C.sub.1-C.sub.12)-alkyl, (C.sub.3-C.sub.12)-cycloalkyl, (C.sub.3-C.sub.12)-heterocycloalkyl, (C.sub.6-C.sub.20)-aryl, (C.sub.3-C.sub.20)-heteroaryl; at least one of the R.sup.1, R.sup.2, R.sup.3, R.sup.4 radicals is a (C.sub.3-C.sub.20)-heteroaryl radical; and R.sup.1, R.sup.2, R.sup.3, R.sup.4, if they are (C.sub.1-C.sub.12)-alkyl, (C.sub.3-C.sub.12)-cycloalkyl, (C.sub.3-C.sub.12)-heterocycloalkyl, (C.sub.6-C.sub.20)-aryl or (C.sub.3-C.sub.20)-heteroaryl, may each independently be substituted by one or more substituents selected from (C.sub.1-C.sub.12)-alkyl, (C.sub.3-C.sub.12)-cycloalkyl, (C.sub.3-C.sub.12)-heterocycloalkyl, O(C.sub.1-C.sub.12)-alkyl, O(C.sub.1-C.sub.12)-alkyl-(C.sub.6-C.sub.20)-aryl, O(C.sub.3-C.sub.12)-cycloalkyl, S(C.sub.1-C.sub.12)-alkyl, S(C.sub.3-C.sub.12)-cycloalkyl, COO(C.sub.1-C.sub.12)-alkyl, COO(C.sub.3-C.sub.12)-cycloalkyl, CONH(C.sub.1-C.sub.12)-alkyl, CONH(C.sub.3-C.sub.12)-cycloalkyl, CO(C.sub.1-C.sub.12)-alkyl, CO(C.sub.3-C.sub.12)-cycloalkyl, N[(C.sub.1-C.sub.12)-alkyl].sub.2, (C.sub.6-C.sub.20)-aryl, (C.sub.6-C.sub.20)-aryl-(C.sub.1-C.sub.12)-alkyl, (C.sub.6-C.sub.20)-aryl-O(C.sub.1-C.sub.12)-alkyl, (C.sub.3-C.sub.20)-heteroaryl, (C.sub.3-C.sub.20)-heteroaryl-(C.sub.1-C.sub.12)-alkyl, (C.sub.3-C.sub.20)-heteroaryl-O(C.sub.1-C.sub.12)-alkyl, COOH, OH, SO.sub.3H, NH.sub.2, halogen.

Claims

1. A process for preparing an ester from an ether having 3 to 30 carbon atoms comprising the following process steps: a) introducing the ether having 3 to 30 carbon atoms, forming a reaction mixture; b) adding a phosphine ligand and a compound which comprises Pd, or adding a complex comprising Pd and a phosphine ligand; c) adding an alcohol; d) supplying CO; e) heating the reaction mixture, the ether being reacted to form an ester from the ether, CO and alcohol; where the phosphine ligand is a compound of formula (I) ##STR00011## where m and n are each independently 0 or 1; R.sup.1, R.sup.2, R.sup.3, R.sup.4 are each independently selected from the groups consisting of (C.sub.1-C.sub.12)-alkyl, (C.sub.3-C.sub.12)-cycloalkyl, (C.sub.3-C.sub.12)-heterocycloalkyl, (C.sub.6-C.sub.20)-aryl, and (C.sub.3-C.sub.20)-heteroaryl; where at least one of the R.sup.1, R.sup.2, R.sup.3, R.sup.4 radicals is a (C.sub.3-C.sub.20)-heteroaryl radical; and R.sup.1, R.sup.2, R.sup.3, R.sup.4, if they are (C.sub.1-C.sub.12)-alkyl, (C.sub.3-C.sub.12)-cycloalkyl, (C.sub.3-C.sub.12)-heterocycloalkyl, (C.sub.6-C.sub.20)-aryl or (C.sub.3-C.sub.20)-heteroaryl, may each independently be substituted by one or more substituents selected from the group consisting of (C.sub.1-C.sub.12)-alkyl, (C.sub.3-C.sub.12)-cycloalkyl, (C.sub.3-C.sub.12)-heterocycloalkyl, O(C.sub.1-C.sub.12)-alkyl, O(C.sub.1-C.sub.12)-alkyl-(C.sub.6-C.sub.20)-aryl, O(C.sub.3-C.sub.12)-cycloalkyl, S(C.sub.1-C.sub.12)-alkyl, S(C.sub.3-C.sub.12)-cycloalkyl, COO(C.sub.1-C.sub.12)-alkyl, COO(C.sub.3-C.sub.12)-cycloalkyl, CONH(C.sub.1-C.sub.12)-alkyl, CONH(C.sub.3-C.sub.12)-cycloalkyl, CO(C.sub.1-C.sub.12)-alkyl, CO(C.sub.3-C.sub.12)-cycloalkyl, N[(C.sub.1-C.sub.12)-alkyl].sub.2, (C.sub.6-C.sub.20)-aryl, (C.sub.6-C.sub.20)-aryl-(C.sub.1-C.sub.12)-alkyl, (C.sub.6-C.sub.20)-aryl-O(C.sub.1-C.sub.12)-alkyl, (C.sub.3-C.sub.20)-heteroaryl, (C.sub.3-C.sub.20)-heteroaryl-(C.sub.1-C.sub.12)-alkyl, (C.sub.3-C.sub.20)-heteroaryl-O(C.sub.1-C.sub.12)-alkyl, COOH, OH, SO.sub.3H, NH.sub.2, and halogen; wherein the ether in process step a) is a compound of formula (IV) ##STR00012## where R.sup.5 is selected from the group consisting of (C.sub.1-C.sub.12)-alkyl, (C.sub.3-C.sub.12)-cycloalkyl, and (C.sub.6-C.sub.20)-aryl; R.sup.6 and R.sup.7 each independently are selected from the group consisting of H, (C.sub.1-C.sub.12)-alkyl, (C.sub.3-C.sub.12)-cycloalkyl, and (C.sub.6-C.sub.20)-aryl; and R.sup.8 is selected from the group consisting of (C.sub.1-C.sub.12)-alkyl, (C.sub.3-C.sub.12)-cycloalkyl, and (C.sub.6-C.sub.20)-aryl.

2. The process according to claim 1, where the phosphine ligand is a compound of one of the formulae (II) and (III) ##STR00013##

3. The process according to claim 1, where at least two of the R.sup.1, R.sup.2, R.sup.3, R.sup.4 radicals are a (C.sub.3-C.sub.20)-heteroaryl radical.

4. The process according to claim 1, where the R.sup.1 and R.sup.3 radicals are each a (C.sub.3-C.sub.20)-heteroaryl radical.

5. The process according to claim 1, where the R.sup.1 and R.sup.3 radicals are each a (C.sub.3-C.sub.20)-heteroaryl radical; and R.sup.2 and R.sup.4 are each independently selected from the group consisting of (C.sub.1-C.sub.12)-alkyl, (C.sub.3-C.sub.12)-cycloalkyl, (C.sub.3-C.sub.12)-heterocycloalkyl, and (C.sub.6-C.sub.20)-aryl.

6. The process according to claim 1, where the R.sup.1 and R.sup.3 radicals are each a (C.sub.3-C.sub.20)-heteroaryl radical; and R.sup.2 and R.sup.4 are each independently selected from (C.sub.1-C.sub.12)-alkyl.

7. The process according to claim 1, where R.sup.1, R.sup.2, R.sup.3, R.sup.4, if they are a heteroaryl radical, are each independently selected from the group consisting of furyl, thienyl, pyrrolyl, oxazolyl, isoxazolyl, thiazolyl, isothiazolyl, imidazolyl, pyrazolyl, furazanyl, tetrazolyl, pyridyl, pyridazinyl, pyrimidyl, pyrazinyl, benzofuranyl, indolyl, isoindolyl, benzimidazolyl, quinolyl, and isoquinolyl.

8. The process according to claim 1, where the phosphine ligand is a compound of formula (1) ##STR00014##

9. The process according to claim 1, where R.sup.5 and R.sup.8 are each (C.sub.1-C.sub.12)-alkyl.

10. The process according to claim 1, where R.sup.6 and R.sup.7 each independently are selected from the group consisting of H, (C.sub.1-C.sub.12)-alkyl, and (C.sub.6-C.sub.20)-aryl.

11. The process according to claim 1, where not more than one of the radicals R.sup.6 and R.sup.7 is H.

12. The process according to claim 1, wherein the compound comprising Pd in process step b) is selected from the group consisting of palladium dichloride, palladium(II) acetylacetonate, palladium(II) acetate, dichloro(1,5-cyclooctadiene)palladium(II), bis(dibenzylideneacetone)palladium, bis(acetonitrile)dichloropalladium(II), and palladium(cinnamyl) dichloride.

13. The process according to claim 1, wherein the alcohol in process step c) is selected from the group consisting of methanol, ethanol, 1-propanol, 1-butanol, 1-pentanol, 1-hexanol, 2-propanol, tert-butanol, 3-pentanol, cyclohexanol, and mixtures thereof.

14. The process according to claim 1, wherein the alcohol in process step c) is selected from methanol or ethanol.

Description

EXAMPLES

(1) The examples which follow illustrate the invention.

(2) General Procedures

(3) All the preparations which follow were carried out under protective gas using standard Schlenk techniques. The solvents were dried over suitable desiccants before use (Purification of Laboratory Chemicals, W. L. F. Armarego (Author), Christina Chai (Author), Butterworth Heinemann (Elsevier), 6th edition, Oxford 2009).

(4) Phosphorus trichloride (Aldrich) was distilled under argon before use. All preparative operations were effected in baked-out vessels. The products were characterized by means of NMR spectroscopy. Chemical shifts () are reported in ppm. The .sup.31P NMR signals were referenced as follows: SR.sub.31P=SR.sub.1H*(BF.sub.31P/BF.sub.1H)=SR.sub.1H*0.4048. (Robin K. Harris, Edwin D. Becker, Sonia M. Cabral de Menezes, Robin Goodfellow, and Pierre Granger, Pure Appl. Chem., 2001, 73, 1795-1818; Robin K. Harris, Edwin D. Becker, Sonia M. Cabral de Menezes, Pierre Granger, Roy E. Hoffman and Kurt W. Zilm, Pure Appl. Chem., 2008, 80, 59-84).

(5) The recording of nuclear resonance spectra was effected on Bruker Avance 300 or Bruker Avance 400, gas chromatography analysis on Agilent GC 7890A, elemental analysis on Leco TruSpec CHNS and Varian ICP-OES 715, and ESI-TOF mass spectrometry on Thermo Electron Finnigan MAT 95-XP and Agilent 6890 N/5973 instruments.

Preparation of chloro-2-pyridyl-tert-butylphosphine (Precursor A)

(6) The Grignard for the synthesis of chloro-2-pyridyl-t-butylphosphine is prepared by the Knochel method with isopropylmagnesium chloride (Angew. Chem. 2004, 43, 2222-2226). The workup is effected according to the method of Budzelaar (Organometallics 1990, 9, 1222-1227).

(7) ##STR00007##

(8) 8.07 ml of a 1.3 M isopropylmagnesium chloride solution (Knochel's reagent) are introduced into a 50 ml round-bottom flask with magnetic stirrer and septum, and cooled to 15 C. Thereafter, 953.5 l (10 mmol) of 2-bromopyridine are rapidly added dropwise. The solution immediately turns yellow. It is allowed to warm up to 10 C. The conversion of the reaction is determined as follows: about 100 l solution are taken and introduced into 1 ml of a saturated ammonium chloride solution. If the solution bubbles, not much Grignard has formed yet. The aqueous solution is extracted with a pipette of ether and the organic phase is dried over Na.sub.2SO.sub.4. A GC of the ethereal solution is recorded. When a large amount of pyridine has formed compared to 2-bromopyridine, conversions are high. At 10 C., there has been little conversion. After warming up to room temperature and stirring for 1-2 hours, the reaction solution turns brown-yellow. A GC test shows complete conversion. Now the Grignard solution can be slowly added dropwise with a syringe pump to a solution of 1.748 g (11 mmol) of dichloro-tert-butylphosphine in 10 ml of THF which has been cooled to 15 C. beforehand. It is important that the dichloro-tert-butylphosphine solution is cooled. At room temperature, considerable amounts of dipyridyl-tert-butylphosphine would be obtained. A clear yellow solution is initially formed, which then turns cloudy. The mixture is left to warm up to room temperature and to stir overnight. According to GC-MS, a large amount of product has formed. The solvent is removed under high vacuum and a whitish solid which is brown in places is obtained. The solid is suspended with 20 ml of heptane and the solid is comminuted in an ultrasound bath. After allowing the white solid to settle out, the solution is decanted. The operation is repeated twice with 10-20 ml each time of heptane. After concentration of the heptane solution under high vacuum, it is distilled under reduced pressure. At 4.6 mbar, oil bath 120 C. and distillation temperature 98 C., the product can be distilled. 1.08 g of a colourless oil are obtained. (50%).

(9) Analytical data: .sup.1H NMR (300 MHz, C.sub.6D.sub.6): 8.36 (m, 1H, Py), 7.67 (m, 1H, Py), 7.03-6.93 (m, 1H, Py), 6.55-6.46 (m, 1H, Py), 1.07 (d, J=13.3 Hz, 9H, t-Bu).

(10) .sup.13C NMR (75 MHz, C.sub.6D.sub.6): 162.9, 162.6, 148.8, 135.5, 125.8, 125.7, 122.8, 35.3, 34.8, 25.9 and 25.8.

(11) .sup.31P NMR (121 MHz, C.sub.6D.sub.6) 97.9.

(12) MS (EI) m:z (relative intensity) 201 (M.sup.+, 2), 147(32), 145 (100), 109 (17), 78 (8), 57.1 (17).

Preparation of Ligand 1 (,-bis(2-pyridyl(t-butyl)phosphino)o-xylene)

(13) ##STR00008##

(14) 675 mg (27.8 mmol, 4 eq) of Mg powder are weighed out in a glovebox in a 250 ml round-bottom flask with a nitrogen tap and magnetic stirrer bar, and the flask is sealed with a septum. High vacuum is applied to the round-bottom flask (about 510.sup.2 mbar) and it is heated to 90 C. for 45 minutes. After cooling down to room temperature, 2 grains of iodine are added and the mixture is dissolved in 20 ml of THF. The suspension is stirred for about 10 minutes until the yellow colour of the iodine has disappeared. After the magnesium powder has settled out, the cloudy THF solution is decanted and the activated magnesium powder is washed twice with 1-2 ml of THF. Then another 20 ml of fresh THF are added. At room temperature, a solution of 1.21 g (6.9 mmol) of ,-dichloro-o-xylene in 70 ml of THE is slowly added dropwise with a syringe pump. The THF solution gradually turns a darker colour. The next day, the THF suspension is filtered to remove the unconverted magnesium powder and the content of Grignard compound is determined as follows:

(15) 1 ml of Grignard solution is quenched in a saturated aqueous solution of NH.sub.4Cl and extracted with ether. After drying over Na.sub.2SO.sub.4, a GC of the ether solution is recorded. In qualitative terms, it is observed that exclusively o-xylene has formed.

(16) Quantitative determination of the content of the Grignard solution:

(17) 1 ml of Grignard solution is quenched with 2 ml of 0.1 M HCl and the excess acid is titrated with 0.1 M NaOH. A suitable indicator is an aqueous 0.04% bromocresol solution. The colour change goes from yellow to blue. 0.74 ml of 0.1 M NaOH has been consumed. 2 ml-0.74 ml=1.26 ml, corresponding to 0.126 mmol of Grignard compound. Since a di-Grignard is present, the Grignard solution is 0.063 M. This is a yield exceeding 90%.

(18) In a 250 ml three-neck flask with reflux condenser and magnetic stirrer, under argon, 1.8 g (8.66 mmol) of chlorophosphine (2-Py(tBu)PCl) are dissolved in 10 ml of THF and cooled to 60 C. Then 55 ml of the above-stipulated Grignard solution (0.063 M, 3.46 mmol) are slowly added dropwise at this temperature with a syringe pump. The solution at first remains clear and then turns intense yellow. After 1.5 hours, the solution turns cloudy. The mixture is left to warm up to room temperature overnight and a clear yellow solution is obtained. To complete the reaction, the mixture is heated under reflux for 1 hour. After cooling, 1 ml of H.sub.2O is added and the solution loses colour and turns milky white. After removing THF under high vacuum, a stringy, pale yellow solid is obtained. 10 ml of water and 10 ml of ether are added thereto, and two homogeneous clear phases are obtained, which have good separability. The aqueous phase is extracted twice with ether. After the organic phase has been dried with Na.sub.2SO.sub.4, the ether is removed under high vacuum and a stringy, almost colourless solid is obtained. The latter is dissolved in 5 ml of MeOH while heating on a water bath and filtered through Celite. At 28 C., 772 mg of product are obtained in the form of white crystals overnight. (51%). After concentration, it was possible to isolate another 100 mg from the mother solution. The overall yield is 57.6%.

(19) .sup.1H NMR (300 MHz, C.sub.6D.sub.6): 8.58 (m, 2H, Py), 7.31-7.30 (m, 2H, benzene), 7.30-7.22 (m, 2H, Py), 6.85-6.77 (m, 2H, Py), 6.73 (m, 2H, benzene), 6.57-6.50 (m, 2H, py), 4.33 (dd, J=13.3 and 4.3 Hz, 2H, CH.sub.2), 3.72-3.62 (m, 2H, CH.sub.2), 121 (d, J=11.8 Hz, 18H, tBu),

(20) .sup.13C NMR (75 MHz, C.sub.6D.sub.6): 161.3, 161.1, 149.6, 137.8, 137.7, 134.5, 133.3, 132.7, 131.4, 131.3, 125.7, 122.9, 30.7, 30.5, 28.2, 28.0, 26.5, 26.4, 26.2, and 26.1.

(21) .sup.31P NMR (121 MHz, C.sub.6D.sub.6) 8.8, EA calculated for C.sub.26H.sub.34N.sub.2P.sub.2: C, 71.54; H, 7.85; N, 6.56; P, 14.35. found: C, 71.21; H, 7.55; N, 6.56; P, 14.35.

Methoxycarbonylation of methyl tert-butyl ether (MTBE)

(22) ##STR00009##

1) No Ligand (Comparative Example)

(23) A 4 ml glass reaction vessel (vial) is charged under argon with Pd(acac).sub.2 (1.52 mg, 0.25 mol %), PTSA (14.3 mg, 3.75 mol %) and a magnetic stirrer. Then MeOH (2 ml) and MTBE (0.24 ml, 2 mmol) are added under argon. This vial is placed in a metal plate fabricated for the purpose, and the plate with vial is transferred into a 300 ml autoclave from Parr Instruments. The autoclave is purged three times with CO and then charged with 50 bar of CO at room temperature. The reaction is carried out with magnetic stirring at 120 C. for 20 hours. After cooling down to room temperature, the autoclave is carefully let down. The yield was conducted by GC analysis with isooctane (200 l) as internal standard (0% yield of methyl 3-methylbutaonate).

2) 1,2-bis(di-tert-butylphosphinomethyl)benzene (Ligand 3) (Comparison Example)

(24) ##STR00010##

(25) A 4 ml glass reaction vessel (vial) is charged under argon with Pd(acac).sub.2 (1.52 mg, 0.25 mol %), PTSA (14.3 mg, 3.75 mol %), 3 (8.72 mg, 1 mol %) and a magnetic stirrer. Then MeOH (2 ml) and MTBE (0.24 ml, 2 mmol) are added under argon. This vial is placed in a metal plate fabricated for the purpose, and the plate with vial is transferred into a 300 ml autoclave from Parr Instruments. The autoclave is purged three times with CO and then charged with 50 bar of CO at room temperature. The reaction is carried out with magnetic stirring at 120 C. for 20 hours. After cooling down to room temperature, the autoclave is carefully let down. The yield was conducted by GC analysis with isooctane (200 l) as internal standard (0% yield of methyl 3-methylbutaonate).

3) Ligand 1

(26) A 4 ml glass reaction vessel (vial) is charged under argon with Pd(acac).sub.2 (1.52 mg, 0.25 mol %), PTSA (14.3 mg, 3.75 mol %), 1 (8.7 mg, 1 mol %) and a magnetic stirrer. Then MeOH (2 ml) and MTBE (0.24 ml, 2 mmol) are added under argon. This vial is placed in a metal plate fabricated for the purpose, and the plate with vial is transferred into a 300 ml autoclave from Parr Instruments. The autoclave is purged three times with CO and then charged with 50 bar of CO at room temperature. The reaction is carried out with magnetic stirring at 120 C. for 20 hours. After cooling down to room temperature, the autoclave is carefully let down. The yield was conducted by GC analysis with isooctane (200 l) as internal standard (73% yield of methyl 3-methylbutaonate).

(27) The results are summarised in the following table:

(28) TABLE-US-00001 Yield of methyl Example Ligand Solvent 3-methylbutanoate 1 (CE) methanol 0% 2 (CE) 3 methanol 0% 3 1 methanol 73% CE: Comparative example

(29) This experiment shows that with the process according to the invention it is possible to react ethers with alcohols and CO to form the corresponding esters. In this reaction, significant yields are achieved only using the inventively employed ligands, but not with the ligand 3 known from the prior art. The invention therefore enables the use of ethers in place of ethylenically unsaturated compounds as a starting material for the alkoxycarbonylation.